Search

everythinglearnresearchcommunity

for

Search:↓

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

Ruxolitinib can help regrow hair in severe alopecia areata.

STAT5 activation is crucial for starting the hair growth phase.

Ruxolitinib effectively and safely regrows hair in alopecia patients.

Abrocitinib may effectively treat stubborn alopecia universalis.

Targeting JAK-STAT1 can reduce inflammation and promote hair growth in conditions linked to EGFR deficiency.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

Naringin may help treat atopic dermatitis by reducing inflammation and improving the skin barrier.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

The authors suggest that 5-α-reductase inhibitors, like dutasteride, are effective in treating frontal fibrosing alopecia and should be the first-line treatment, with other options for severe cases. They also recommend further research on Janus kinase inhibitors.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Baricitinib effectively promotes long-term hair regrowth in alopecia areata patients.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

Baricitinib is an effective treatment for severe alopecia areata.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

Upadacitinib improved multiple immune-related conditions in one patient.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

Combining MMP-9 and JAK inhibitors can effectively prevent skin depigmentation in vitiligo.

JAK inhibitors may help treat certain types of hair loss, but more research is needed.

Abrocitinib helped a 14-year-old girl with severe alopecia areata regrow her hair significantly.

Topical ruxolitinib and oral minoxidil together can regrow hair in certain types of hair loss.

High testosterone levels can harm fertility by disrupting the LIF signaling pathway in the uterus.